PMID- 31591335 OWN - NLM STAT- MEDLINE DCOM- 20200224 LR - 20200224 IS - 1660-4601 (Electronic) IS - 1661-7827 (Print) IS - 1660-4601 (Linking) VI - 16 IP - 19 DP - 2019 Oct 7 TI - Effect of Paecilomyces tenuipes Extract on Testosterone-Induced Benign Prostatic Hyperplasia in Sprague-Dawley Rats. LID - 10.3390/ijerph16193764 [doi] LID - 3764 AB - : Benign prostatic hyperplasia (BPH) is one of the major public health concerns, which has a high prevalence rate and causes significant decline in men's quality of life. BPH is highly related to sexual hormone metabolism and aging. In particular, dihydrotestosterone (DHT), to which testosterone is modified by 5alpha-reductase (5AR), has a significant effect on BPH development. DHT binds to an androgen receptor (AR) and steroid receptor coactivator 1 (SRC-1); then, it induces the proliferation of a prostate cell and expression of prostate specific antigen (PSA). Paecilomyces tenuipes (P. tenuipes) is a mushroom that has been popularized by the artificial cultivation of fruiting bodies based on silkworms by researchers from the Republic of Korea. In a previous study, we identified the effect of PE on PSA mRNA expression in LNCaP cells. This suggests that PE may have an inhibitory effect on androgen signaling. Therefore, we confirmed the expression of androgen signaling-related factors, such as AR, SRC-1, and PSA in LNCaP. Furthermore, we confirmed the androgen signaling inhibitory effect of PE using the testosterone propionate (TP)-induced BPH rat model. A BPH rat model was established with a four-week treatment of daily subcutaneous injections of testosterone propionate (TP, 3 mg/kg) dissolved in corn oil after castration. The rats in the treatment group were orally gavaged P. tenuipes extract (PE), finasteride (Fi), or saw palmetto extract (Saw) with TP injection. DHT induced an increase in the expression levels of AR, SRC-1, and PSA proteins in LNCaP cells. On the contrary, the PE treatment reduced the expression levels. In vivo, the BPH group showed an increase in prostate size compared with the control group. The PE gavaged group showed a decrease in prostate size compared with the BPH group. In addition, the protein expressions of AR, 5AR2, and PSA were significantly lower in the PE gavaged group than BPH group in prostate tissue. These results suggest the beneficial effects of PE on BPH via the modulation of AR signaling pathway. FAU - Choi, Young-Jin AU - Choi YJ AD - Division of Food Bioscience, College of Biomedical and Health Sciences, Konkuk University, Chungju 27478, Korea. FAU - Kim, Eun-Kyung AU - Kim EK AD - Division of Food Bioscience, College of Biomedical and Health Sciences, Konkuk University, Chungju 27478, Korea. FAU - Fan, Meiqi AU - Fan M AD - Division of Food Bioscience, College of Biomedical and Health Sciences, Konkuk University, Chungju 27478, Korea. FAU - Tang, Yujiao AU - Tang Y AD - Division of Food Bioscience, College of Biomedical and Health Sciences, Konkuk University, Chungju 27478, Korea. AD - School of Bio-science and Food Engineering, Changchun University of Science and Technology, Changchun 130-600, China. FAU - Hwang, Young Joung AU - Hwang YJ AD - Department of Food Science & Culinary, International University of Korea, Jinju 52833, Korea. FAU - Sung, Si-Heung AU - Sung SH AD - Division of Food Bioscience, College of Biomedical and Health Sciences, Konkuk University, Chungju 27478, Korea. shsung@kku.ac.kr. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20191007 PL - Switzerland TA - Int J Environ Res Public Health JT - International journal of environmental research and public health JID - 101238455 RN - 0 (Plant Extracts) RN - 0 (Receptors, Androgen) RN - 3XMK78S47O (Testosterone) SB - IM MH - Animals MH - Disease Models, Animal MH - Male MH - Paecilomyces/*chemistry MH - Plant Extracts/*pharmacology MH - Prostatic Hyperplasia/*drug therapy/physiopathology MH - Rats MH - Rats, Sprague-Dawley MH - Receptors, Androgen/metabolism MH - Testosterone/*metabolism PMC - PMC6801653 OTO - NOTNLM OT - Paecilomyces tenuipes OT - benign prostatic hyperplasia OT - testosterone COIS- The authors declare no conflict of interest. EDAT- 2019/10/09 06:00 MHDA- 2020/02/25 06:00 PMCR- 2019/10/01 CRDT- 2019/10/09 06:00 PHST- 2019/08/13 00:00 [received] PHST- 2019/10/03 00:00 [revised] PHST- 2019/10/03 00:00 [accepted] PHST- 2019/10/09 06:00 [entrez] PHST- 2019/10/09 06:00 [pubmed] PHST- 2020/02/25 06:00 [medline] PHST- 2019/10/01 00:00 [pmc-release] AID - ijerph16193764 [pii] AID - ijerph-16-03764 [pii] AID - 10.3390/ijerph16193764 [doi] PST - epublish SO - Int J Environ Res Public Health. 2019 Oct 7;16(19):3764. doi: 10.3390/ijerph16193764.